Cardiac Biomarker Kinetics and Their Association With Magnetic Resonance Measures of Cardiomyocyte Integrity Following a Marathon Run: Implications for Postexercise Biomarker Testing
- PMID: 34180243
- PMCID: PMC8403309
- DOI: 10.1161/JAHA.120.020039
Cardiac Biomarker Kinetics and Their Association With Magnetic Resonance Measures of Cardiomyocyte Integrity Following a Marathon Run: Implications for Postexercise Biomarker Testing
Conflict of interest statement
EMD Merck Millipore (Hayward, CA) was contracted to undertake the analyses of cardiac myosin–binding protein C on a fee‐for‐service basis and holds no commercial interest. Dr Marber is named as an inventor on a patent held by King's College London for the detection of cardiac myosin–binding protein C as a biomarker of myocardial injury. The remaining authors have no disclosures to report.
Figures

References
-
- Aengevaeren VL, Froeling M, Hooijmans MT, Monte JR, van den Berg‐Faay S, Hopman MTE, Strijkers GJ, Nederveen AJ, Bakermans AJ, Eijsvogels TMH. Myocardial injury and compromised cardiomyocyte integrity following a marathon run. JACC Cardiovasc Imaging. 2020;13:1445–1447. DOI: 10.1016/j.jcmg.2019.12.020. - DOI - PubMed
-
- Kaier TE, Twerenbold R, Puelacher C, Marjot J, Imambaccus N, Boeddinghaus J, Nestelberger T, Badertscher P, Sabti Z, Giménez MR, et al. Direct comparison of cardiac myosin‐binding protein C with cardiac troponins for the early diagnosis of acute myocardial infarction. Circulation. 2017;136:1495–1508. DOI: 10.1161/CIRCULATIONAHA.117.028084. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources